Add Yahoo as a preferred source to see more of our stories on Google. An 11-year-old boy recently became the first person in the world to have an artificial heart valve replaced with a living donor ...

A study led by the University of Bristol, Bristol, England, has found that mechanical heart valves provide better long-term survival than biological heart valves in patients aged 50-70 years. The ...

Add Yahoo as a preferred source to see more of our stories on Google. Mary Ann George had a question for Dr. George D'Angelo, shortly after the groundbreaking Erie heart surgeon replaced two of her ...

According to the American Heart Association, valvular heart disease affects about 2.5% of adults in the United States, and more than 100,000 patients undergo valve replacement surgery each year.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

PORTLAND Ore. (KPTV) - A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s valve center. As a part of FOX 12’s ...

A groundbreaking heart procedure at MedStar Union Memorial Hospital has made Maryland history. Joan Mertz, 83, became the first patient in the state to undergo an artificial heart valve replacement ...

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol ...

A research team led by Bristol and Cambridge universities has demonstrated that the polymer material used to make a new artificial heart valve is safe following a six-month test in sheep. Currently, ...

Federal health officials are asking safety questions about the first artificial heart valve designed to be implanted without major surgery, in advance of a meeting Wednesday to consider broadening its ...

CHICAGO — Edoxaban, a direct oral anticoagulant, appeared to be as effective as or more effective than warfarin in preventing thromboembolism — such as stroke, systemic embolism, or intracardiac ...